National Health Service Act 2006 (c. 41)

Part 7 E+W Pharmaceutical services and local pharmaceutical services

Chapter 5 E+W [F1 Conditional inclusion in pharmaceutical lists, and supplementary lists][F1 Conditional inclusion in pharmaceutical lists]

Textual Amendments

F1 Pt. 7 Ch. 5 heading substituted (27.3.2012 for specified purposes) by Health and Social Care Act 2012 (c. 7), ss. 208(3), 306(1)(d)(4)

148 Conditional inclusion in pharmaceutical lists E+W

(1) Regulations may provide—

(a) that if a person is included in a pharmaceutical list he is subject, while he remains included in the list, to conditions determined by [F2 NHS England],

(b) for [F2 NHS England] to vary that person's terms of service for the purpose of or in connection with the imposition of any such conditions,

(c) for [F2 NHS England] to vary the conditions or impose different ones,

(d) for the consequences of failing to comply with a condition (including removal from the list), and

(e) for the review by [F2 NHS England] of any decision made by virtue of the regulations.

(2) The imposition of conditions must be with a view to—

(a) preventing any prejudice to the efficiency of the services in question, or

(b) preventing any acts or omissions within section 151(3)(a).

(3) If regulations provide for a practitioner's removal from the list for breach of condition—

(a) the regulations may provide that he may not withdraw from the list while [F2 NHS England] is investigating whether there are grounds for exercising their power to remove him, or after [F2 NHS England] has decided to remove him but before it has given effect to that decision, and

(b) the regulations must include provision—

(i) requiring the practitioner to be given notice of any allegation against him,

(ii) giving him the opportunity of putting his case at a hearing before [F2 NHS England] makes any decision as to his removal from the list, and

(iii) requiring him to be given notice of the decision of [F2 NHS England] and the reasons for it and of his right of appeal under subsection (4).

(4) If regulations provide as mentioned in subsection (1), they must also provide for an appeal by the person in question to the [F3 First-tier Tribunal] against the decision of [F2 NHS England]—

(a) to impose conditions, or any particular condition,

(b) to vary a condition,

(c) to vary his terms of service,

(d) on any review of an earlier such decision of [F2 NHS England],

(e) to remove him from the list for breach of condition,

and the appeal must be by way of redetermination of the decision of [F2 NHS England].

(5) The regulations may provide for any such decision not to have effect until the determination by the [F4 First-tier Tribunal] of any appeal against it, and must so provide in relation to a decision referred to in subsection (4)(e).

(6) Regulations under this section may provide for the disclosure by [F2 NHS England], to prescribed persons or persons of prescribed descriptions, of information of a prescribed description—

(a) about persons whose inclusion in a pharmaceutical list is subject to conditions imposed under this section, and

(b) about the removal of such persons from a pharmaceutical list for breach of condition.

(7) In this Part, “terms of service” means the terms upon which, by virtue of regulations, a person undertakes to provide pharmaceutical services.

Textual Amendments

F2 Words in Act substituted (1.7.2022) by Health and Care Act 2022 (c. 31), s. 186(6), Sch. 1 para. 1(1)(2); S.I. 2022/734, reg. 2(a), Sch. (with regs. 13, 29, 30)

F3 Words in s. 148(4) substituted (18.1.2010) by The Transfer of Tribunal Functions Order 2010 (S.I. 2010/22), art. 1(1), Sch. 2 para. 113 (with Sch. 5)

F4 Words in s. 148(5) substituted (18.1.2010) by The Transfer of Tribunal Functions Order 2010 (S.I. 2010/22), art. 1(1), Sch. 2 para. 113 (with Sch. 5)